+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Omics Lab Services Market Size, Share & Industry Trends Analysis Report By Business (Diagnostic Labs, Research Institutes, and Hospitals), By End Use, By Type, By Product, By Frequency of Service, By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 326 Pages
  • December 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5723521
The Global Omics Lab Services Market size is expected to reach $139.1 billion by 2028, rising at a market growth of 12.9% CAGR during the forecast period.

A biological science branch of study that ends in omics, like genomics, proteomics, transcriptomics, or metabolomics, is referred to as omics. Omics strives to characterize and quantify large groups of biological molecules that are relevant to an organism's or a group of organisms' structure, function,
and dynamics.



The goal of functional genomics is to determine the functions of as many genes in a particular organism as feasible. Transcriptomics, proteomics, and saturated mutant collections are combined with other -omics approaches.

The market for omics lab services is expanding as a result of factors including rising customer demand and acceptance of the services as well as rising company involvement. For instance, to speed up therapeutic target identification utilizing AI-based genomic analysis, Illumina, Inc., and AstraZeneca engaged in a strategic alliance in October 2022.

Further study into the genetic susceptibility to certain illnesses has been made possible by the expansion of the genomic data pool as a result of research efforts. The clinical use of this data pool is anticipated to revolutionize the healthcare system by enabling the delivery of more precise, efficient, and dependable disease management solutions. The industrial and healthcare sectors are working to effectively integrate genetic data into clinical procedures, despite the fact that clinical usage of genomic data is still in its infancy.

The creation of diagnostic tools based on omics research is still in its infancy. The challenge for developers in the next years will be to provide outcomes that are reliable and timely enough to show the clinical value of such tests. Such examples will be necessary to convince healthcare professionals to use the tests and convince other parties to pay for their costs.

COVID-19 Impact Analysis

Due to the COVID-19 pandemic, 2020 experienced unheard-of growth. A variety of cancer immunotherapies have been evaluated using advanced omics technologies, including single-cell omics, multi-omics, and conventional omics techniques. Additionally, the industry is being driven by the increasing use of 'multi-omics' in research and the use of sophisticated sequencing platforms in the context of precision medicine. COVID-19 has significantly disrupted the pharmaceutical industry's supply chain as a whole. In order to comprehend the COVID-19 virus, several small businesses have begun omics-based clinical studies.

Market Growth Factors

The Massive Investment of the Government for Genomics Projects

Governments in a number of nations have made considerable investments in genomics in recent years. These government investments have aided the development of new technology significantly. For instance, The Department of Biotechnology (DBT) launched the 'Genome India Project (GIP)' in January 2020. The goal of the initiative is to collect 10, 000 genetic samples from Indian residents in order to create a reference genome. Precision health, rare genetic illnesses, the mutation spectrum of genetic and complex diseases in the Indian population, genetic epidemiology of multifactorial lifestyle diseases, and translational research are some of the areas of focus of this project.

NGS Platforms' On-going Technical Breakthroughs

Continuous technical breakthroughs in sequencing methods have made it possible to create effective, portable, and user-friendly NGS systems with a shorter turnaround time and the ability to offer rapid and accurate findings. Leading corporations are increasing their R&D spending in order to strengthen their market positions and share since the launch of such items and technologies gives them an instant competitive advantage. Technical advancements have led to the addition of several new bioinformatics tools to metagenomics, increasing market revenue.

Market Restraining Factor

A Scarcity of Qualified Professionals

Data from omics can be utilized for a wide number of purposes, such as pharmacogenomics, diagnostics, and toxicogenomics. In some circumstances, technical improvements have made it possible for the instruments in use to give an analysis; however, the reader's interpretation is still up to them. It is vital to recruiting skilled professionals to evaluate and interpret the outcomes of sequencing data due to the intricacies involved and the requirement for an in-depth understanding of omics.

Business Outlook

Based on the business, the Omics Lab Services Market is divided into Hospitals, Research Institutes, and Diagnostic Labs. In 2021, Diagnostic Labs segment accounted for the largest revenue share in the market. The rise in testing and the accessibility of resources for conducting tests are responsible for the segment's expansion. Improved hospital dependence on diagnostic labs for testing and assessment is contributing to the segment's increased growth.



End-Use Outlook

Based on End-Use, the omics lab services market is categorized into Cancer, Pharmaco, Reproductive, Other Genetic Tests, Forensics, Population Studies, Skincare, Nutrition, Vitamins and Supplements, Genealogy, and Others. The reproductive segment acquired the considerable revenue share in the market in 2021. The study of oocytes (or the somatic cells surrounding them) and embryos, where the low quantity of material significantly decreases the information accessible when compared with somatic tissues, is the first clear area to profit from the capacity to amplify DNA (using PCR-type reactions). The number of unidentified genes discovered to be expressed in oocytes or cumulus cells as opposed to granulosa cells nowadays still reflects this.

Type Outlook

Based on type, the Omics Lab Services Market is classified into Genomics, Proteomics, Transcriptomic, Metabolomics, and Epigenetics. The epigenetics segment garnered the significant revenue share in the market during 2021. The future potential provided by the epigenetic analysis is responsible for the segment's expansion. Businesses in the omics lab services market are concentrating on expanding their product and service portfolios for this market segment. For instance, Eisbach Bio and MD Anderson collaborated strategically to create a drug that targets epigenetics in cancer in January 2022.

Product Outlook

Based on product, the omics lab services market is classified into Hardware Equipment (Instrument, Kits, and Chips), Testing / Lab (Services), and Analytics / Interpretation (Personalization and Interpretation). The hardware equipment segment registered the highest share in the market in 2021. The instruments used in genomic applications are likely to get smaller, which will boost market expansion. Specificity, sensitivity, and automation are benefits provided by tiny devices in the development of point-of-care diagnostics.

Frequency of Service Outlook

Based on the frequency of service, the omics lab services market is classified into One-off, Repeat, and Continuous segments. In 2021, the continuous segment led the market for omics lab services. Genetic technologies are increasingly being used at all periods of life, including old age and the postmortem stage. The use of genetic technology in healthcare creates unique ethical issues that endanger existing therapeutic modalities. These challenges include the varying definitions of value for genetic information.

Regional Outlook

Based on geography, the Omics Lab Services Market is divided into North America, Europe, Asia Pacific, and LAMEA. Due to the high accuracy, specificity, and sensitivity of genetic testing, North America led the global omics lab services market in 2021, which may be ascribed to this region's growing use of genetic testing. Market expansion is predicted to be fueled by the growing demand for genetic testing in clinical studies, including customized healthcare for diseases like diabetes and cancer.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience

Strategies Deployed in Omics Lab Services Market

  • Nov-2022: Quest Diagnostics took over LabCare Plus, the outreach laboratory services business of Summa Health. Under this acquisition, Quest Diagnostics acquired selected assets of LabCare Plus. Moreover, Quest Diagnostics would widen access to insights and diagnostic innovations, empowering improved health for more communities in Northeastern Ohio.
  • Feb-2022: PhenoSwitch Bioscience came into collaboration with Proteoform Scientific, a proteomics sample preparation technology developer, and manufacturer. Under this collaboration, PhenoSwitch Bioscience along with Proteoform would provide better value in data analytics, sample prep, and mass spec, combining all these important components in a flawless customer experience.
  • Jan-2022: Illumina, Inc., partnered with SomaLogic, a company that works in data-driven proteomics technology. Under this partnership, Illumina would be able to develop and deploy NGS-based protein identification and measurement tools in laboratories internationally. Moreover, this would promote the expansion and use of high-plex protein pattern recognition tests.
  • Apr-2021: Agilent Technologies took over Resolution Bioscience, the company engaged in the commercialization and development of next-generation sequencing (NGS)-based precision oncology solutions. The latter company's liquid biopsy-based diagnostic technologies reinforced the former company's portfolio to clinical diagnostics and biopharma customers and increased the growth opportunities of Agilent's genomics and diagnostic business.
  • Sep-2020: Qiagen NV took over NeuMoDx Molecular Inc., a molecular diagnostics company. Under this acquisition, Qiagen NV would enhance its portfolio of automated testing solutions and deliver another driver for future development. Moreover, the complete integration of Qiagen NV and NeuMoDx systems would allow Qiagen NV to handle laboratory requirements in any environment for molecular diagnostics.
  • Jun-2020: Q2 Solutions partnered with Thermo Fisher Scientific, a provider of end-to-end drug development offering that includes Biologics, API, and viral vector services. Following this partnership, Q2 Solutions would use Ion Torrent Genexus System. Furthermore, adding the Ion Torrent Genexus System capabilities would enable Q2 Solutions to drastically decrease the time to provide clinical reports to trial sites, therefore helping patients access investigational drugs faster.
  • Nov-2018: Quest Diagnostics completed the acquisition of the U.S. laboratory services business of Oxford Immunotec, a diagnostics company focused on commercializing and developing proprietary tests. Through this acquisition, Quest Diagnostics would buy and use T-SPOT.TB test kits and related accessories.
  • Jan-2018: Agilent Technologies completed the acquisition of Luxcel Biosciences, a company focused on the productization and development of optical sensor technologies. The acquisition increased Agilent's growth into Biopharma/Pharma discovery and in vitro toxicology-screening applications.

Scope of the Study

By Business

  • Diagnostic Labs
  • Research Institutes
  • Hospitals

By End-Use

  • Cancer
  • Pharmaco
  • Population Studies & Genealogy
  • Reproductive
  • Skincare
  • Nutrition, Vitamin & Supplements
  • Forensics & Others

By Type

  • Proteomics
  • Transcriptomic
  • Metabolomics
  • Genomics
  • Epigenetics

By Product

  • Hardware Equipment
  • Testing / Lab Services
  • Analytics / Interpretation

By Frequency of Service

  • Continuous
  • Repeat
  • One-off

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • BGI Group
  • Q2 Solutions (IQVIA)
  • Flomics Biotech
  • PhenoSwitch Bioscience

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Omics Lab Services Market, by Business
1.4.2 Global Omics Lab Services Market, by End-Use
1.4.3 Global Omics Lab Services Market, by Type
1.4.4 Global Omics Lab Services Market, by Product
1.4.5 Global Omics Lab Services Market, by Frequency of Service
1.4.6 Global Omics Lab Services Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Omics Lab Services Market

Chapter 4. Global Omics Lab Services Market by Business
4.1 Global Diagnostic Labs Market by Region
4.2 Global Research Institutes Market by Region
4.3 Global Hospitals Market by Region

Chapter 5. Global Omics Lab Services Market by End-Use
5.1 Global Cancer Market by Region
5.2 Global Pharmaco Market by Region
5.3 Global Population Studies & Genealogy Market by Region
5.4 Global Reproductive Market by Region
5.5 Global Skincare Market by Region
5.6 Global Nutrition, Vitamin & Supplements Market by Region
5.7 Global Forensics & Others Market by Region

Chapter 6. Global Omics Lab Services Market by Type
6.1 Global Proteomics Market by Region
6.2 Global Transcriptomic Market by Region
6.3 Global Metabolomics Market by Region
6.4 Global Genomics Market by Region
6.5 Global Epigenetics Market by Region

Chapter 7. Global Omics Lab Services Market by Product
7.1 Global Hardware Equipment Market by Region
7.2 Global Testing / Lab Services Market by Region
7.3 Global Analytics / Interpretation Market by Region

Chapter 8. Global Omics Lab Services Market by Frequency of Service
8.1 Global Continuous Market by Region
8.2 Global Repeat Market by Region
8.3 Global One-off Market by Region

Chapter 9. Global Omics Lab Services Market by Region
9.1 North America Omics Lab Services Market
9.1.1 North America Omics Lab Services Market by Business
9.1.1.1 North America Diagnostic Labs Market by Country
9.1.1.2 North America Research Institutes Market by Country
9.1.1.3 North America Hospitals Market by Country
9.1.2 North America Omics Lab Services Market by End-Use
9.1.2.1 North America Cancer Market by Country
9.1.2.2 North America Pharmaco Market by Country
9.1.2.3 North America Population Studies & Genealogy Market by Country
9.1.2.4 North America Reproductive Market by Country
9.1.2.5 North America Skincare Market by Country
9.1.2.6 North America Nutrition, Vitamin & Supplements Market by Country
9.1.2.7 North America Forensics & Others Market by Country
9.1.3 North America Omics Lab Services Market by Type
9.1.3.1 North America Proteomics Market by Country
9.1.3.2 North America Transcriptomic Market by Country
9.1.3.3 North America Metabolomics Market by Country
9.1.3.4 North America Genomics Market by Country
9.1.3.5 North America Epigenetics Market by Country
9.1.4 North America Omics Lab Services Market by Product
9.1.4.1 North America Hardware Equipment Market by Country
9.1.4.2 North America Testing / Lab Services Market by Country
9.1.4.3 North America Analytics / Interpretation Market by Country
9.1.5 North America Omics Lab Services Market by Frequency of Service
9.1.5.1 North America Continuous Market by Country
9.1.5.2 North America Repeat Market by Country
9.1.5.3 North America One-off Market by Country
9.1.6 North America Omics Lab Services Market by Country
9.1.6.1 US Omics Lab Services Market
9.1.6.1.1 US Omics Lab Services Market by Business
9.1.6.1.2 US Omics Lab Services Market by End-Use
9.1.6.1.3 US Omics Lab Services Market by Type
9.1.6.1.4 US Omics Lab Services Market by Product
9.1.6.1.5 US Omics Lab Services Market by Frequency of Service
9.1.6.2 Canada Omics Lab Services Market
9.1.6.2.1 Canada Omics Lab Services Market by Business
9.1.6.2.2 Canada Omics Lab Services Market by End-Use
9.1.6.2.3 Canada Omics Lab Services Market by Type
9.1.6.2.4 Canada Omics Lab Services Market by Product
9.1.6.2.5 Canada Omics Lab Services Market by Frequency of Service
9.1.6.3 Mexico Omics Lab Services Market
9.1.6.3.1 Mexico Omics Lab Services Market by Business
9.1.6.3.2 Mexico Omics Lab Services Market by End-Use
9.1.6.3.3 Mexico Omics Lab Services Market by Type
9.1.6.3.4 Mexico Omics Lab Services Market by Product
9.1.6.3.5 Mexico Omics Lab Services Market by Frequency of Service
9.1.6.4 Rest of North America Omics Lab Services Market
9.1.6.4.1 Rest of North America Omics Lab Services Market by Business
9.1.6.4.2 Rest of North America Omics Lab Services Market by End-Use
9.1.6.4.3 Rest of North America Omics Lab Services Market by Type
9.1.6.4.4 Rest of North America Omics Lab Services Market by Product
9.1.6.4.5 Rest of North America Omics Lab Services Market by Frequency of Service
9.2 Europe Omics Lab Services Market
9.2.1 Europe Omics Lab Services Market by Business
9.2.1.1 Europe Diagnostic Labs Market by Country
9.2.1.2 Europe Research Institutes Market by Country
9.2.1.3 Europe Hospitals Market by Country
9.2.2 Europe Omics Lab Services Market by End-Use
9.2.2.1 Europe Cancer Market by Country
9.2.2.2 Europe Pharmaco Market by Country
9.2.2.3 Europe Population Studies & Genealogy Market by Country
9.2.2.4 Europe Reproductive Market by Country
9.2.2.5 Europe Skincare Market by Country
9.2.2.6 Europe Nutrition, Vitamin & Supplements Market by Country
9.2.2.7 Europe Forensics & Others Market by Country
9.2.3 Europe Omics Lab Services Market by Type
9.2.3.1 Europe Proteomics Market by Country
9.2.3.2 Europe Transcriptomic Market by Country
9.2.3.3 Europe Metabolomics Market by Country
9.2.3.4 Europe Genomics Market by Country
9.2.3.5 Europe Epigenetics Market by Country
9.2.4 Europe Omics Lab Services Market by Product
9.2.4.1 Europe Hardware Equipment Market by Country
9.2.4.2 Europe Testing / Lab Services Market by Country
9.2.4.3 Europe Analytics / Interpretation Market by Country
9.2.5 Europe Omics Lab Services Market by Frequency of Service
9.2.5.1 Europe Continuous Market by Country
9.2.5.2 Europe Repeat Market by Country
9.2.5.3 Europe One-off Market by Country
9.2.6 Europe Omics Lab Services Market by Country
9.2.6.1 Germany Omics Lab Services Market
9.2.6.1.1 Germany Omics Lab Services Market by Business
9.2.6.1.2 Germany Omics Lab Services Market by End-Use
9.2.6.1.3 Germany Omics Lab Services Market by Type
9.2.6.1.4 Germany Omics Lab Services Market by Product
9.2.6.1.5 Germany Omics Lab Services Market by Frequency of Service
9.2.6.2 UK Omics Lab Services Market
9.2.6.2.1 UK Omics Lab Services Market by Business
9.2.6.2.2 UK Omics Lab Services Market by End-Use
9.2.6.2.3 UK Omics Lab Services Market by Type
9.2.6.2.4 UK Omics Lab Services Market by Product
9.2.6.2.5 UK Omics Lab Services Market by Frequency of Service
9.2.6.3 France Omics Lab Services Market
9.2.6.3.1 France Omics Lab Services Market by Business
9.2.6.3.2 France Omics Lab Services Market by End-Use
9.2.6.3.3 France Omics Lab Services Market by Type
9.2.6.3.4 France Omics Lab Services Market by Product
9.2.6.3.5 France Omics Lab Services Market by Frequency of Service
9.2.6.4 Russia Omics Lab Services Market
9.2.6.4.1 Russia Omics Lab Services Market by Business
9.2.6.4.2 Russia Omics Lab Services Market by End-Use
9.2.6.4.3 Russia Omics Lab Services Market by Type
9.2.6.4.4 Russia Omics Lab Services Market by Product
9.2.6.4.5 Russia Omics Lab Services Market by Frequency of Service
9.2.6.5 Spain Omics Lab Services Market
9.2.6.5.1 Spain Omics Lab Services Market by Business
9.2.6.5.2 Spain Omics Lab Services Market by End-Use
9.2.6.5.3 Spain Omics Lab Services Market by Type
9.2.6.5.4 Spain Omics Lab Services Market by Product
9.2.6.5.5 Spain Omics Lab Services Market by Frequency of Service
9.2.6.6 Italy Omics Lab Services Market
9.2.6.6.1 Italy Omics Lab Services Market by Business
9.2.6.6.2 Italy Omics Lab Services Market by End-Use
9.2.6.6.3 Italy Omics Lab Services Market by Type
9.2.6.6.4 Italy Omics Lab Services Market by Product
9.2.6.6.5 Italy Omics Lab Services Market by Frequency of Service
9.2.6.7 Rest of Europe Omics Lab Services Market
9.2.6.7.1 Rest of Europe Omics Lab Services Market by Business
9.2.6.7.2 Rest of Europe Omics Lab Services Market by End-Use
9.2.6.7.3 Rest of Europe Omics Lab Services Market by Type
9.2.6.7.4 Rest of Europe Omics Lab Services Market by Product
9.2.6.7.5 Rest of Europe Omics Lab Services Market by Frequency of Service
9.3 Asia Pacific Omics Lab Services Market
9.3.1 Asia Pacific Omics Lab Services Market by Business
9.3.1.1 Asia Pacific Diagnostic Labs Market by Country
9.3.1.2 Asia Pacific Research Institutes Market by Country
9.3.1.3 Asia Pacific Hospitals Market by Country
9.3.2 Asia Pacific Omics Lab Services Market by End-Use
9.3.2.1 Asia Pacific Cancer Market by Country
9.3.2.2 Asia Pacific Pharmaco Market by Country
9.3.2.3 Asia Pacific Population Studies & Genealogy Market by Country
9.3.2.4 Asia Pacific Reproductive Market by Country
9.3.2.5 Asia Pacific Skincare Market by Country
9.3.2.6 Asia Pacific Nutrition, Vitamin & Supplements Market by Country
9.3.2.7 Asia Pacific Forensics & Others Market by Country
9.3.3 Asia Pacific Omics Lab Services Market by Type
9.3.3.1 Asia Pacific Proteomics Market by Country
9.3.3.2 Asia Pacific Transcriptomic Market by Country
9.3.3.3 Asia Pacific Metabolomics Market by Country
9.3.3.4 Asia Pacific Genomics Market by Country
9.3.3.5 Asia Pacific Epigenetics Market by Country
9.3.4 Asia Pacific Omics Lab Services Market by Product
9.3.4.1 Asia Pacific Hardware Equipment Market by Country
9.3.4.2 Asia Pacific Testing / Lab Services Market by Country
9.3.4.3 Asia Pacific Analytics / Interpretation Market by Country
9.3.5 Asia Pacific Omics Lab Services Market by Frequency of Service
9.3.5.1 Asia Pacific Continuous Market by Country
9.3.5.2 Asia Pacific Repeat Market by Country
9.3.5.3 Asia Pacific One-off Market by Country
9.3.6 Asia Pacific Omics Lab Services Market by Country
9.3.6.1 China Omics Lab Services Market
9.3.6.1.1 China Omics Lab Services Market by Business
9.3.6.1.2 China Omics Lab Services Market by End-Use
9.3.6.1.3 China Omics Lab Services Market by Type
9.3.6.1.4 China Omics Lab Services Market by Product
9.3.6.1.5 China Omics Lab Services Market by Frequency of Service
9.3.6.2 Japan Omics Lab Services Market
9.3.6.2.1 Japan Omics Lab Services Market by Business
9.3.6.2.2 Japan Omics Lab Services Market by End-Use
9.3.6.2.3 Japan Omics Lab Services Market by Type
9.3.6.2.4 Japan Omics Lab Services Market by Product
9.3.6.2.5 Japan Omics Lab Services Market by Frequency of Service
9.3.6.3 India Omics Lab Services Market
9.3.6.3.1 India Omics Lab Services Market by Business
9.3.6.3.2 India Omics Lab Services Market by End-Use
9.3.6.3.3 India Omics Lab Services Market by Type
9.3.6.3.4 India Omics Lab Services Market by Product
9.3.6.3.5 India Omics Lab Services Market by Frequency of Service
9.3.6.4 South Korea Omics Lab Services Market
9.3.6.4.1 South Korea Omics Lab Services Market by Business
9.3.6.4.2 South Korea Omics Lab Services Market by End-Use
9.3.6.4.3 South Korea Omics Lab Services Market by Type
9.3.6.4.4 South Korea Omics Lab Services Market by Product
9.3.6.4.5 South Korea Omics Lab Services Market by Frequency of Service
9.3.6.5 Singapore Omics Lab Services Market
9.3.6.5.1 Singapore Omics Lab Services Market by Business
9.3.6.5.2 Singapore Omics Lab Services Market by End-Use
9.3.6.5.3 Singapore Omics Lab Services Market by Type
9.3.6.5.4 Singapore Omics Lab Services Market by Product
9.3.6.5.5 Singapore Omics Lab Services Market by Frequency of Service
9.3.6.6 Malaysia Omics Lab Services Market
9.3.6.6.1 Malaysia Omics Lab Services Market by Business
9.3.6.6.2 Malaysia Omics Lab Services Market by End-Use
9.3.6.6.3 Malaysia Omics Lab Services Market by Type
9.3.6.6.4 Malaysia Omics Lab Services Market by Product
9.3.6.6.5 Malaysia Omics Lab Services Market by Frequency of Service
9.3.6.7 Rest of Asia Pacific Omics Lab Services Market
9.3.6.7.1 Rest of Asia Pacific Omics Lab Services Market by Business
9.3.6.7.2 Rest of Asia Pacific Omics Lab Services Market by End-Use
9.3.6.7.3 Rest of Asia Pacific Omics Lab Services Market by Type
9.3.6.7.4 Rest of Asia Pacific Omics Lab Services Market by Product
9.3.6.7.5 Rest of Asia Pacific Omics Lab Services Market by Frequency of Service
9.4 LAMEA Omics Lab Services Market
9.4.1 LAMEA Omics Lab Services Market by Business
9.4.1.1 LAMEA Diagnostic Labs Market by Country
9.4.1.2 LAMEA Research Institutes Market by Country
9.4.1.3 LAMEA Hospitals Market by Country
9.4.2 LAMEA Omics Lab Services Market by End-Use
9.4.2.1 LAMEA Cancer Market by Country
9.4.2.2 LAMEA Pharmaco Market by Country
9.4.2.3 LAMEA Population Studies & Genealogy Market by Country
9.4.2.4 LAMEA Reproductive Market by Country
9.4.2.5 LAMEA Skincare Market by Country
9.4.2.6 LAMEA Nutrition, Vitamin & Supplements Market by Country
9.4.2.7 LAMEA Forensics & Others Market by Country
9.4.3 LAMEA Omics Lab Services Market by Type
9.4.3.1 LAMEA Proteomics Market by Country
9.4.3.2 LAMEA Transcriptomic Market by Country
9.4.3.3 LAMEA Metabolomics Market by Country
9.4.3.4 LAMEA Genomics Market by Country
9.4.3.5 LAMEA Epigenetics Market by Country
9.4.4 LAMEA Omics Lab Services Market by Product
9.4.4.1 LAMEA Hardware Equipment Market by Country
9.4.4.2 LAMEA Testing / Lab Services Market by Country
9.4.4.3 LAMEA Analytics / Interpretation Market by Country
9.4.5 LAMEA Omics Lab Services Market by Frequency of Service
9.4.5.1 LAMEA Continuous Market by Country
9.4.5.2 LAMEA Repeat Market by Country
9.4.5.3 LAMEA One-off Market by Country
9.4.6 LAMEA Omics Lab Services Market by Country
9.4.6.1 Brazil Omics Lab Services Market
9.4.6.1.1 Brazil Omics Lab Services Market by Business
9.4.6.1.2 Brazil Omics Lab Services Market by End-Use
9.4.6.1.3 Brazil Omics Lab Services Market by Type
9.4.6.1.4 Brazil Omics Lab Services Market by Product
9.4.6.1.5 Brazil Omics Lab Services Market by Frequency of Service
9.4.6.2 Argentina Omics Lab Services Market
9.4.6.2.1 Argentina Omics Lab Services Market by Business
9.4.6.2.2 Argentina Omics Lab Services Market by End-Use
9.4.6.2.3 Argentina Omics Lab Services Market by Type
9.4.6.2.4 Argentina Omics Lab Services Market by Product
9.4.6.2.5 Argentina Omics Lab Services Market by Frequency of Service
9.4.6.3 UAE Omics Lab Services Market
9.4.6.3.1 UAE Omics Lab Services Market by Business
9.4.6.3.2 UAE Omics Lab Services Market by End-Use
9.4.6.3.3 UAE Omics Lab Services Market by Type
9.4.6.3.4 UAE Omics Lab Services Market by Product
9.4.6.3.5 UAE Omics Lab Services Market by Frequency of Service
9.4.6.4 Saudi Arabia Omics Lab Services Market
9.4.6.4.1 Saudi Arabia Omics Lab Services Market by Business
9.4.6.4.2 Saudi Arabia Omics Lab Services Market by End-Use
9.4.6.4.3 Saudi Arabia Omics Lab Services Market by Type
9.4.6.4.4 Saudi Arabia Omics Lab Services Market by Product
9.4.6.4.5 Saudi Arabia Omics Lab Services Market by Frequency of Service
9.4.6.5 South Africa Omics Lab Services Market
9.4.6.5.1 South Africa Omics Lab Services Market by Business
9.4.6.5.2 South Africa Omics Lab Services Market by End-Use
9.4.6.5.3 South Africa Omics Lab Services Market by Type
9.4.6.5.4 South Africa Omics Lab Services Market by Product
9.4.6.5.5 South Africa Omics Lab Services Market by Frequency of Service
9.4.6.6 Nigeria Omics Lab Services Market
9.4.6.6.1 Nigeria Omics Lab Services Market by Business
9.4.6.6.2 Nigeria Omics Lab Services Market by End-Use
9.4.6.6.3 Nigeria Omics Lab Services Market by Type
9.4.6.6.4 Nigeria Omics Lab Services Market by Product
9.4.6.6.5 Nigeria Omics Lab Services Market by Frequency of Service
9.4.6.7 Rest of LAMEA Omics Lab Services Market
9.4.6.7.1 Rest of LAMEA Omics Lab Services Market by Business
9.4.6.7.2 Rest of LAMEA Omics Lab Services Market by End-Use
9.4.6.7.3 Rest of LAMEA Omics Lab Services Market by Type
9.4.6.7.4 Rest of LAMEA Omics Lab Services Market by Product
9.4.6.7.5 Rest of LAMEA Omics Lab Services Market by Frequency of Service

Chapter 10. Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 Agilent Technologies, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Acquisition and Mergers:
10.3 Qiagen N.V.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.4 Quest Diagnostics Incorporated
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Illumina, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 BGI Group
10.6.1 Company Overview
10.7 Q2 Solutions (IQVIA)
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Partnerships, Collaborations, and Agreements:
10.8 Flomics Biotech
10.8.1 Company Overview
10.9 PhenoSwitch Bioscience
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • BGI Group
  • Q2 Solutions (IQVIA)
  • Flomics Biotech
  • PhenoSwitch Bioscience

Methodology

Loading
LOADING...